Small Cap Feast

15th January 2024

Dish of the day
No Joiners today
Off the menu
No leavers today


Dish Of The Day:


Admissions: 



Delistings:




Whats baking in the oven?

Potential Initial Public Offerings:


Reverse Takeovers:


Change of Market:


Banquet Buffet

Audioboom Group 312.5p £51.2m (BOOM.L)
The leading global podcast Company provides a trading update for the year ended 31 December 2023. In 2023, revenue is approximately US$65.0m, down 13% (2022: US$74.9m) and adjusted EBITDA loss is c. US$1.5m (2022: US$3.6m in profit). Group cash was US$3.7m at 31 December 2023, up from US$0.7m on 30 September 2023 with a further US$1.8m available via an undrawn overdraft. The Company has contracted revenue of more than US$47.0m for 2024, through advance bookings during a positive advertising season. The Company anticipates record revenue in 2024, with operational improvements and a return to adjusted EBITDA profitability.

Filtronic 22p £48.0m (FTC.L)
The designer and manufacturer of products for the aerospace, defence, telecoms infrastructure and low earth orbit space markets announces a new contract win with QinetiQ, a global defence and security Company. Phase 1 of the contract is valued at £2.0m and the revenue is expected to be recognised over the next two years. This contract is for the development of a radio-frequency (RF) subsystem to be installed into a range radar solution either as a vehicle mounted land system or a helicopter mounted mobile solution.

Fulcrum Metals 15.95p £8.0m (FMET.L)
The Company focused on mineral exploration and development in Canada provides a update on its Saskatchewan based exploration assets. Dahrouge Geological Consulting Limited, an Alberta-based group with wide experience in uranium project exploration and evaluation, has completed 2023 year-end reports on Fulcrum's Charlot-Neely and Fontaine Lake uranium properties which detail results of the positive 2023 prospecting and sampling programs carried out on both properties. A total of 62 rock samples collected across Charlot-Neely and Fontaine Lake properties: Charlot-Neely Project (48 rock samples assaying up to 5,680ppm U) and Fontaine Lake Property (14 rock samples assaying up to 7,130ppm U). Ppm U being parts per million (ppm) of uranium (U).

Hercules Site Services 26.25p £16.0m (HERC.L)
The technology enabled labour supply Company for the UK infrastructure sector announces its audited results for the year ended 30 September. Revenues grew 71% to a record £84.7m (2022: £49.5m), adjusted EBITDA increased 79% to a record £4.1m (2022: £2.3m) and the cash at the year end was £4.2m (2022: £1.2m). The business has a strong pipeline of projects heading into 2024. Hercules is well positioned to take advantage of secular trends in both the infrastructure and construction sectors. Management will also continue to pursue a disciplined approach to M&A to accelerate the growth of the Company.

Iofina 24.5p £47.0m (IOF.L)
The specialists in the exploration and production of iodine and manufacturers of specialty chemical products provides a business update. With IO#9 plant operating at an improved production rate in the second half of Q4 2023, crystalline iodine production across Iofina Resources' six plants for the last quarter increased year over year by 16% to 160.9 metric tonnes (MT). Total production during the second half was 317.8MT. Total crystalline iodine production in 2023 was up 8% to 559.3MT from 2022. The iodine spot price softened by circa 5% over H2 2023 towards mid-to-upper sixties dollars per kilogram as prices have settled from historically high levels. Moving into 2024, the market fundamentals of the iodine business remain strong and Iofina currently expects the spot price to remain at present levels for the foreseeable future.

One Heritage Group* 14p £5.4m (OHG.L)
The UK-based residential developer, development manager and property manager focused on the North of England, announced that its parent company and majority shareholder One Heritage Property Development Ltd (OHPD), in support of the Company, has extended by 12 months the repayment of its £14m debt facility until the 31 December 2025.

OptiBiotix Health 25.5p £23.3m (OPTI.L)
The life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skincare announces the forthcoming launch of LeanBiome in Muscletech, one of the leading sports nutrition brands in the industry and backed by America's No. 1 selling sports supplement company. The product is currently being advertised on social media by the Company's partner ahead of online and instore launches with multiple retailers in Sweden, France, Poland, Germany, the Netherlands, Greece and the UK.

Ramsdens Holdings 200p £63.4m (RFX.L)
The diversified financial services provider and retailer announces its results for the year ended 30 September 2023 (Fy23). Revenue increased 27% to £83.8m (FY22: £66.1m) and profit before tax was £10.1m, up 22% (FY22: £8.3m), driven by strong performances across all four key income streams. In Q1 FY24 (October to December 2023), ongoing demand for small sum short term credit has enabled the pawnbroking loan book to incrementally increase to £10.6m from the year end position of £10.3m. The Group is currently trading in line with the Board's expectations.

Union Jack Oil 20.5p £21.8m (UJO.L)
The UK focused onshore hydrocarbon production, development and exploration Company announces that material net revenues in excess of US$18m have been achieved from the Wressle hydrocarbon development (Wressle), located within licences PEDL180 and PEDL182 in North Lincolnshire on the western margin of the Humber Basin. Union Jack holds a 40% economic interest in this development. Wressle-1 well gross production is currently averaging a constrained 665 barrels of oil per day. Union Jack continues to be cash flow positive covering all planned G&A, OPEX and CAPEX liabilities. Cash, short term receivables and investments at 12 January 2024, were in excess of £9.45m. Union Jack is debt free and remains highly cash generative.

Zenova Group 3.25p £3.5m (ZED.L)
The innovative fire suppression and interdiction solutions Company announces its expansion into Spain, Portugal, and Central and South America markets through the signing of a sales and distribution agreement for its entire range of heat management and fire safety solutions with E-Z International. The exclusive agreement will cover an initial period of three years and can continue if the Agent achieves a minimum sales target level of £100,000 per annum. If the sales target minimum is not met, the agreement becomes non-exclusive.

15 January 2024
*A corporate client of Hybridan LLP or retained by Hybridan LLP for certain services
** Arranged by most recent first
*** Alphabetically arranged
**** Potential means Intention to Float (ITF) has been announced, or it is a rumour

STAY INFORMED

Our daily digest of news from UK listed Small and Mid caps straight to your Inbox.

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.

© Copyright 2024 - Hybridan | Website by Boxed Up Media
First Visit
bookcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram